Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
- Author(s)
- Saw, SPL; Zhong, WZ; Fu, R; Li, MSC; Goto, Y; Fox, SB; Yatabe, Y; Ong, BH; Ng, CSH; Lee, DDW; Cam Phuong, P; Park, IK; Yang, JCH; Tsuboi, M; Tho, LM; John, T; Hsu, HH; Tan, DSW; Mok, TSK; Reungwetwattana, T; Singh, N;
- Journal Title
- Lung Cancer
- Publication Type
- Online publication before print
- Abstract
- The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.
- Keywords
- Asian; Consensus statement; Nsclc; Peri-operative
- Department(s)
- Medical Oncology; Pathology
- Publisher's Version
- https://doi.org/10.1016/j.lungcan.2024.108076
- Open Access at Publisher's Site
https://doi.org/10.1016/j.lungcan.2024.108076- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-01-23 02:18:52
Last Modified: 2025-01-23 02:30:24